You can set up to four test reminders, three of which can be timed and one post meal test reminders. CareSens N Technical Information The CareSens N Blood Glucose Monitor offers easy and accurate testing and there’s no coding required. for treating chronic heart failure with reduced ejection fraction as per NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.

For your patients with diabetes who are currently prescribed Toujeo® DoubleStar: A guide on how to use Toujeo® DoubleStar. Meter is restricted for use in people with needle phobia, paediatrics, visual impairments and physical impairments requiring single-handed use For your patients with diabetes who are currently prescribed Lantus ®: A step-by-step guide on how to use Lantus® SoloStar.For the treatment of patients with Type 1 or Type 2 diabetes who have nocturnal hypoglycaemia and are on ≥80 units of basal analogue insulin (e.g. Abasaglar®, Lantus®, Levemir® or Semglee®)

Pioglitazone should not be used in people who have heart failure or who are at higher risk of fracture. Continue Pioglitazone therapy only if there is a reduction of ≥0.5 percentage points in HbA1c in 6 months. Monitor for liver toxicity. There is risk of bladder cancer with pioglitazone. Do not use in active bladder cancer or a past history of bladder cancer, or in those who have uninvestigated macroscopic haematuria. Assess risks for bladder cancer after 3-6months of starting pioglitazone. Refer to current BNF for full contraindications and interactions SLGT2 inhibitors are not to beused inprimary care for type 1 diabetes until further local guidance becomes available For your patients with diabetes who are currently prescribed Toujeo® DoubleStar: A video on how to use Toujeo® DoubleStar. Formulary for the listed indications that meet the NHSE criteria as proposed in annex A of the following linked guidance document

For your patients with diabetes who are currently prescribed Toujeo® SoloStar: A video on how to use Toujeo® SoloStar.

Select a desired depth of one – to – seven (1-7) on the lancing device’s adjustable tip. Choose a depth by rotating the top portion of the adjustable tip until the setting number matches the arrow. Patients are required to wait at least 30 minutes before eating/drinking or taking other oral medicinal products. Waiting less than 30 minutes decreases absorption. Meal markers can be attached to tests to show which tests were pre-meal tests and which were post-meal tests. Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.For the treatment of patients with Type 2 diabetes who have nocturnal / severe hypoglycaemia or those with recurrent hypoglycaemic episodes requiring hospital admission Semaglutide is a biological medicine. Biological medicines must be prescribed and dispensed by brand name, see Biological medicines and Biosimilar medicines , under Guidance on Prescribing ; manufacturer advises to record the brand name and batch number after each administration. For your patients with diabetes who are currently prescribed Insuman® Basal: A step-by-step guide on how to use Insuman® Basal SoloStar. SLGT2 inhibitors are not to beused inprimary care for type 1 diabetes until further local guidance becomes available. See DMMAG Type 2 Diabetes Mellitus - Guideline for the choice of oral and non-insulin antidiabetic agents for adults

Caution - retinopathy. Do not use in patients withpre-proliferative/proliferativeretinopathy (R2/R3 grade)or maculopathy (M1)or who are undergoing or awaiting eye laser or intravitreal treatments. Ensure all patients areup-to-date with theirretinopathy screening programmeprior to initiation of semaglutide, and thattheyattend their annual screening whilst on treatment. Firmly insert a new lancet into the lancet holder. Hold the lancet firmly. Gently twist to pull off the protective disk. Save disk to recap lancet after use. Replace lancet device tip. Using the latest technology, CareSens N monitors use a highly specific glucose oxidase reagent that will only measure glucose.Training on the correct use, storage and recording of the readings should be provided by the issuing clinician For usein pregnant women with either gestational diabetes or pre-existing diabetes, after other insulins have been tried and failed to reach post-prandial glucose targets.